Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: SPP007
MIFTS: 39

Suppression Amblyopia

Categories: Neuronal diseases
Genes Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Suppression Amblyopia

About this section

MalaCards integrated aliases for Suppression Amblyopia:

Name: Suppression Amblyopia 12 15
Amblyopia 43 71
Amblyopia, Suppression 71
Strabismic Amblyopia 12

Classifications:

MalaCards categories:
Anatomical: Neuronal diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:10375
ICD9CM 34 368.01
MeSH 43 D000550
SNOMED-CT 67 35600002
ICD10 32 H53.03
UMLS 71 C0002418 C0750903
Sources

Summaries for Suppression Amblyopia

About this section
MalaCards based summary : Suppression Amblyopia, also known as amblyopia, is related to paralytic squint and astigmatism, and has symptoms including photophobia, other specified visual disturbances and visual disturbance. An important gene associated with Suppression Amblyopia is PLAAT3 (Phospholipase A And Acyltransferase 3). The drugs Tropicamide and Atropine have been mentioned in the context of this disorder. Affiliated tissues include eye, testes and cortex.

Sources

Related Diseases for Suppression Amblyopia

About this section

Diseases related to Suppression Amblyopia via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 265, show less)
# Related Disease Score Top Affiliating Genes
1 paralytic squint 32.0 PHOX2A MTRNR2L5
2 astigmatism 31.9 NBL1 DSE
3 esotropia 31.0 PLAAT3 PHOX2A DSE
4 exotropia 30.6 TNFRSF10C PLAAT3 PHOX2A
5 accommodative esotropia 30.6 PLAAT3 PHOX2A
6 aniseikonia 30.5 PLAAT3 DSE
7 hypotropia 30.4 PLAAT3 PHOX2A
8 hypertropia 30.4 PLAAT3 PHOX2A
9 monofixation syndrome 30.3 TNFRSF10C PLAAT3
10 ocular motility disease 30.2 PLAAT3 PHOX2A
11 cycloplegia 30.1 NBL1 DSE
12 anisometropia 30.0 TNFRSF10C PLAAT3 NBL1 DSE A1CF
13 strabismus 29.6 TNFRSF10C PLAAT3 PHOX2A DSE
14 amblyopia 29.3 TNFRSF10C SIRPA PLAAT3 PHOX2A HNMT DSE
15 facial paralysis 29.2 MTRNR2L5 MTRNR2L4
16 ametropic amblyopia 28.7 PHOX2A NBL1 MTRNR2L5 MTRNR2L4 DSE
17 disuse amblyopia 12.5
18 mental and growth retardation with amblyopia 12.2
19 microphthalmia, isolated 6 11.6
20 farsightedness 11.6
21 duane retraction syndrome 1 11.6
22 microphthalmia 11.4
23 peters-plus syndrome 11.4
24 hemifacial hyperplasia with strabismus 11.4
25 isolated ectopia lentis 11.4
26 blepharophimosis, ptosis, and epicanthus inversus 11.2
27 duane retraction syndrome 2 11.2
28 corneal dystrophy, congenital stromal 11.2
29 bestrophinopathy, autosomal recessive 11.2
30 cerulean cataract 11.2
31 aniridia 1 11.1
32 aniridia and absent patella 11.1
33 cataract 41 11.1
34 fibrosis of extraocular muscles, congenital, 1 11.1
35 bornholm eye disease 11.1
36 fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement 11.1
37 mental retardation, anterior maxillary protrusion, and strabismus 11.1
38 cognitive impairment with or without cerebellar ataxia 11.1
39 duane retraction syndrome 3 with or without deafness 11.1
40 aniridia 2 11.1
41 catifa syndrome 11.1
42 cataract microcornea syndrome 11.1
43 hivep2-related intellectual disability 11.1
44 isolated duane retraction syndrome 11.1
45 monocular esotropia 10.8
46 ptosis 10.6
47 refractive error 10.6
48 eye disease 10.6
49 pathologic nystagmus 10.6
50 ocular dominance 10.5
51 congenital ptosis 10.5
52 hemangioma 10.4
53 microvascular complications of diabetes 5 10.4
54 alternating exotropia 10.4
55 scotoma 10.4
56 47,xyy 10.4
57 lacrimal duct defect 10.3
58 optic nerve disease 10.3
59 intraocular pressure quantitative trait locus 10.3
60 achromatopsia 10.2
61 3-methylglutaconic aciduria, type iii 10.2
62 macular degeneration, age-related, 1 10.2
63 familial cold autoinflammatory syndrome 3 10.2
64 joint laxity, short stature, and myopia 10.2
65 myopia 10.2
66 acute retrobulbar neuritis 10.2
67 neuritis 10.2
68 retinal vascular disease 10.2
69 conjunctivitis 10.2
70 cataract 10.2
71 cyclotropia 10.2
72 posttransplant acute limbic encephalitis 10.2
73 ocular motor apraxia 10.2
74 neuropathy 10.2
75 prosopagnosia 10.2 TNFRSF10C HNMT
76 retinal detachment 10.2
77 optic neuritis 10.2
78 uveitis 10.2
79 dyslexia 10.2
80 alcohol dependence 10.1
81 keratoconus 10.1
82 brown's tendon sheath syndrome 10.1
83 blepharophimosis 10.1
84 keratopathy 10.1
85 capillary hemangioma 10.1
86 exudative vitreoretinopathy 1 10.0
87 keratitis, hereditary 10.0
88 retinoblastoma 10.0
89 torticollis 10.0
90 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
91 vitamin b12 deficiency 10.0
92 nutritional optic neuropathy 10.0
93 abnormal retinal correspondence 10.0
94 alcohol use disorder 10.0
95 familial retinoblastoma 10.0
96 crohn's disease 10.0
97 albinism 10.0
98 48,xyyy 10.0
99 color vision deficiency 10.0
100 cerebral visual impairment 10.0
101 hereditary optic neuropathy 10.0
102 mechanical strabismus 10.0
103 epithelial-stromal tgfbi dystrophy 10.0 TNFRSF10C HNMT A1CF
104 lattice corneal dystrophy 10.0 TNFRSF10C HNMT A1CF
105 cleft palate, isolated 10.0
106 corneal dystrophy, posterior polymorphous, 1 10.0
107 optic nerve hypoplasia, bilateral 10.0
108 polykaryocytosis inducer 10.0
109 charge syndrome 10.0
110 leber optic atrophy 10.0
111 kearns-sayre syndrome 10.0
112 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.0
113 brown syndrome 10.0
114 ocular albinism 10.0
115 persistent hyperplastic primary vitreous 10.0
116 autosomal dominant non-syndromic intellectual disability 1 10.0
117 sleeping sickness 10.0
118 trypanosomiasis 10.0
119 synostosis 10.0
120 lagophthalmos 10.0
121 color blindness 10.0
122 cerebral palsy 10.0
123 craniosynostosis 10.0
124 corneal dystrophy 10.0
125 astrocytoma 10.0
126 macular retinal edema 10.0
127 retinal disease 10.0
128 peripheral nervous system disease 10.0
129 juvenile pilocytic astrocytoma 10.0
130 chickenpox 10.0
131 neurofibromatosis 10.0
132 keratoconjunctivitis 10.0
133 neurofibroma 10.0
134 syndromic craniosynostosis 10.0
135 pik3ca-related overgrowth syndrome 10.0
136 yemenite deaf-blind hypopigmentation syndrome 9.9
137 cranial nerve disease 9.8 PLAAT3 PHOX2A
138 abducens palsy 9.8
139 adie pupil 9.8
140 alzheimer disease 9.8
141 anisocoria 9.8
142 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.8
143 catatrichy 9.8
144 coloboma of macula 9.8
145 deafness, unilateral 9.8
146 epicanthus 9.8
147 epidermoid cysts 9.8
148 hand skill, relative 9.8
149 attention deficit-hyperactivity disorder 9.8
150 lipomatosis, multiple 9.8
151 moebius syndrome 9.8
152 pernicious anemia 9.8
153 prader-willi syndrome 9.8
154 sturge-weber syndrome 9.8
155 chromosome 2q35 duplication syndrome 9.8
156 telecanthus 9.8
157 vitiligo-associated multiple autoimmune disease susceptibility 6 9.8
158 williams-beuren syndrome 9.8
159 autism 9.8
160 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.8
161 corneal dystrophy, band-shaped 9.8
162 persistent hyperplastic primary vitreous, autosomal recessive 9.8
163 myasthenia gravis 9.8
164 retinitis pigmentosa 9.8
165 retinoschisis of fovea 9.8
166 coats disease 9.8
167 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 9.8
168 retinoschisis 1, x-linked, juvenile 9.8
169 ataxia and polyneuropathy, adult-onset 9.8
170 stroke, ischemic 9.8
171 branchiootic syndrome 1 9.8
172 pars planitis 9.8
173 meningioma, radiation-induced 9.8
174 vitiligo-associated multiple autoimmune disease susceptibility 1 9.8
175 body mass index quantitative trait locus 1 9.8
176 meningioma, familial 9.8
177 myopia 6 9.8
178 myopia 9 9.8
179 human immunodeficiency virus type 1 9.8
180 leptin deficiency or dysfunction 9.8
181 carbonic anhydrase va deficiency, hyperammonemia due to 9.8
182 deficiency anemia 9.8
183 foodborne botulism 9.8
184 posterior polar cataract 9.8
185 brachydactyly 9.8
186 fetal alcohol spectrum disorder 9.8
187 metabolic acidosis 9.8
188 proximal symphalangism 9.8
189 autism spectrum disorder 9.8
190 aphasia 9.8
191 sclerocornea 9.8
192 cornea plana 9.8
193 anterior segment dysgenesis 9.8
194 fibrous dysplasia 9.8
195 nanophthalmos 9.8
196 familial woolly hair syndrome 9.8
197 neuroretinitis 9.8
198 pleomorphic lipoma 9.8
199 juvenile glaucoma 9.8
200 meningocele 9.8
201 amnestic disorder 9.8
202 hemiplegia 9.8
203 corneal edema 9.8
204 chlamydia 9.8
205 keratomalacia 9.8
206 pituitary apoplexy 9.8
207 arteriovenous malformation 9.8
208 lens subluxation 9.8
209 spinal meningioma 9.8
210 accommodative spasm 9.8
211 presbyopia 9.8
212 goiter 9.8
213 dysentery 9.8
214 entropion 9.8
215 intermediate uveitis 9.8
216 quadriplegia 9.8
217 shipyard eye 9.8
218 alexia 9.8
219 irregular astigmatism 9.8
220 lacrimal duct obstruction 9.8
221 methylmalonic acidemia 9.8
222 cholera 9.8
223 conversion disorder 9.8
224 pulmonary tuberculosis 9.8
225 cellulitis 9.8
226 retinitis 9.8
227 articulation disorder 9.8
228 juvenile xanthogranuloma 9.8
229 hypotrichosis 9.8
230 secretory meningioma 9.8
231 lymphoplasmacyte-rich meningioma 9.8
232 endophthalmitis 9.8
233 somatoform disorder 9.8
234 movement disease 9.8
235 cavernous hemangioma 9.8
236 neurotic disorder 9.8
237 plexiform neurofibroma 9.8
238 placenta disease 9.8
239 corneal ulcer 9.8
240 night blindness 9.8
241 herpes simplex 9.8
242 learning disability 9.8
243 waardenburg's syndrome 9.8
244 exophthalmos 9.8
245 iridocyclitis 9.8
246 congenital nystagmus 9.8
247 meibomian cyst 9.8
248 adamtsl4-related eye disorders 9.8
249 isolated methylmalonic acidemia 9.8
250 encephalocele 9.8
251 neonatal stroke 9.8
252 vernal keratoconjunctivitis 9.8
253 weber syndrome 9.8
254 depression 9.8
255 dysphagia 9.8
256 headache 9.8
257 traumatic brain injury 9.8
258 basal encephalocele 9.8
259 spasmus nutans 9.8
260 cyanide poisoning 9.8
261 juvenile myasthenia gravis 9.8
262 extensive peripapillary myelinated nerve fibers 9.8
263 digitalis poisoning 9.8
264 eye accommodation disease 9.8 TNFRSF10C NBL1 DSE
265 facial nerve disease 9.7 MTRNR2L5 MTRNR2L4

Graphical network of the top 20 diseases related to Suppression Amblyopia:



Diseases related to Suppression Amblyopia
Sources

Symptoms & Phenotypes for Suppression Amblyopia

About this section

UMLS symptoms related to Suppression Amblyopia:


photophobia, other specified visual disturbances, visual disturbance
Sources

Drugs & Therapeutics for Suppression Amblyopia

About this section

Drugs for Suppression Amblyopia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 90, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tropicamide Approved, Investigational Phase 4 1508-75-4 5593
2
Atropine Approved, Vet_approved Phase 4 51-55-8, 5908-99-6 174174
3
Donepezil Approved Phase 4 120014-06-4 3152
4
Brinzolamide Approved Phase 4 138890-62-7 68844
5
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
6
Nepafenac Approved, Investigational Phase 4 78281-72-8 151075
7
Cefpirome Approved Phase 4 84957-29-9 5479539
8
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
9
Sotalol Approved Phase 4 3930-20-9, 959-24-0 5253
10 Mydriatics Phase 4
11 Respiratory System Agents Phase 4
12 Parasympatholytics Phase 4
13 Anti-Asthmatic Agents Phase 4
14 Muscarinic Antagonists Phase 4
15 Cholinergic Antagonists Phase 4
16 Bronchodilator Agents Phase 4
17 Cholinesterase Inhibitors Phase 4
18 Ophthalmic Solutions Phase 4
19 Anti-Inflammatory Agents Phase 4
20 Carbonic Anhydrase Inhibitors Phase 4
21 Ketorolac Tromethamine Phase 4
22 Analgesics, Non-Narcotic Phase 4
23 Analgesics Phase 4
24 Cyclooxygenase Inhibitors Phase 4
25 Antirheumatic Agents Phase 4
26 Anti-Inflammatory Agents, Non-Steroidal Phase 4
27 Anti-Infective Agents Phase 4
28 Anti-Bacterial Agents Phase 4
29 Norgestimate, ethinyl estradiol drug combination Phase 4
30 Antibiotics, Antitubercular Phase 4
31 Sodium Channel Blockers Phase 4
32 Sympatholytics Phase 4
33 Diuretics, Potassium Sparing Phase 4
34
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
35
Levodopa Approved Phase 3 59-92-7 6047
36
Carbidopa Approved Phase 3 28860-95-9 34359
37
Acetazolamide Approved, Vet_approved Phase 2, Phase 3 59-66-5 1986
38
Acetaminophen Approved Phase 2, Phase 3 103-90-2 1983
39
Ibuprofen Approved Phase 2, Phase 3 15687-27-1 3672
40
Naproxen Approved, Vet_approved Phase 2, Phase 3 22204-53-1 1302 156391
41
Guaifenesin Approved, Investigational, Vet_approved Phase 2, Phase 3 93-14-1 3516
42
Codeine Approved, Illicit Phase 2, Phase 3 76-57-3 5284371
43
Aspirin Approved, Vet_approved Phase 2, Phase 3 50-78-2 2244
44 Dopamine Agents Phase 3
45 Antiparkinson Agents Phase 3
46 Aromatic Amino Acid Decarboxylase Inhibitors Phase 3
47 Antitussive Agents Phase 2, Phase 3
48 Narcotics Phase 2, Phase 3
49 Fibrinolytic Agents Phase 2, Phase 3
50 Platelet Aggregation Inhibitors Phase 2, Phase 3
51 diuretics Phase 2, Phase 3
52 Antipyretics Phase 2, Phase 3
53 Chlorpheniramine, phenylpropanolamine drug combination Phase 2, Phase 3
54 Anticonvulsants Phase 2, Phase 3
55 Analgesics, Opioid Phase 2, Phase 3
56
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
57 Trace Elements Phase 2
58 Vitamins Phase 2
59 Vitamin B Complex Phase 2
60 Nutrients Phase 2
61 Folate Phase 2
62 Micronutrients Phase 2
63 Vitamin B9 Phase 2
64 Omega 3 Fatty Acid Phase 1, Phase 2
65
Edetic Acid Approved, Vet_approved Phase 1 60-00-4, 62-33-9 6049
66
Pentetic acid Approved Phase 1 67-43-6
67
Ethanol Approved Phase 1 64-17-5 702
68
Benzyl alcohol Approved Phase 1 100-51-6 244
69
Maleic acid Experimental, Investigational Phase 1 110-17-8, 110-16-7 444972
70 Antidotes Phase 1
71
Calcium carbonate Approved, Investigational 471-34-1
72 Tomato Approved
73
Cocaine Approved, Illicit 50-36-2 446220 5760
74
Dexamethasone acetate Approved, Investigational, Vet_approved 1177-87-3
75
Dexamethasone Approved, Investigational, Vet_approved 50-02-2 5743
76
Propranolol Approved, Investigational 525-66-6 4946
77
Acetylcholine Approved, Investigational 51-84-3 187
78
Methamphetamine Approved, Illicit 537-46-2 10836
79 Curare
80 Hormones
81 Antineoplastic Agents, Hormonal
82 Hormone Antagonists
83 Antiemetics
84 glucocorticoids
85 Gastrointestinal Agents
86 Antioxidants
87 Anesthetics
88 Cholinergic Agents
89 Botulinum Toxins
90 Sympathomimetics

Interventional clinical trials:

(showing 171, show less)
# Name Status NCT ID Phase Drugs
1 Pilot Study of Prevention Myopia in Children With Low Concentration of Atropine Unknown status NCT00541177 Phase 4 atropine;tropicamide
2 The Effect of Donepezil on Perceptual Learning in Adult Amblyopia Completed NCT03109314 Phase 4 Donepezil
3 A Randomized Trial Comparing Daily Atropine Versus Weekend Atropine Completed NCT00094614 Phase 4 Atropine
4 Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome Completed NCT01312402 Phase 4 topical brinzolamide 1% in 5mL ophthalmic medication;Placebo in 5 mL dispenser
5 Mini-flared Kelman Tip and Reverse Tip With Torsional Phaco: Prospective Randomized Comparative Study Completed NCT02089698 Phase 4
6 Comparison of Ketorolac Tromethamine 0.4% and Nepafenac 0.1% for the Prevention of Cystoid Macular Edema After Phacoemulsification: Prospective Randomized Double-masked Study Completed NCT02084576 Phase 4 Nepafenac;Ketorolac
7 Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration Completed NCT00280514 Phase 4 cefpirome and moxifloxacin administration
8 A Prospective, Multi-Center, Randomized, Open Label Trial to Determine if a Common Atrial Fibrillation Risk Locus Modulates Differential Response to Antiarrhythmic Drugs Not yet recruiting NCT02347111 Phase 4 Flecainide;Sotalol
9 Topical Timolol for the Treatment of Benign Vascular Periocular Lesions Withdrawn NCT01250457 Phase 4 topical Timolol
10 Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL Implantation Withdrawn NCT00366613 Phase 4
11 Vision In Preschoolers Study (VIP Study) Unknown status NCT00038753 Phase 3
12 Anisometropia Amblyopia Improved by Perceptual Learning and Patching Completed NCT00498641 Phase 3
13 A Randomized Trial of Levodopa as Treatment for Residual Amblyopia (ATS 17) Completed NCT01190813 Phase 3 Levodopa/Carbidopa;Placebo
14 A Randomized Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia Completed NCT00094679 Phase 3
15 Increasing Patching for Amblyopia in Children 3 to < 8 Years Old Completed NCT00945100 Phase 3
16 A Randomized Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old Completed NCT00315198 Phase 3
17 A Randomized Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye As Prescribed Treatments for Amblyopia in Children 3 to <7 Years Old Completed NCT00315302 Phase 3 Atropine
18 A Randomized Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia Completed NCT00094744 Phase 3
19 Electronic Recording of Compliance With Occlusion Therapy for Amblyopia: 1 Effects of Patient Education on Compliance 2 Predictors for Non-Compliance Completed NCT00131729 Phase 3
20 Amblyopia Treatment Study: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia Completed NCT00000170 Phase 3 Atropine
21 Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old Completed NCT00944710 Phase 3 Atropine;Atropine
22 An Evaluation of Treatment of Amblyopia in 7 To <18 Year Olds Completed NCT00094692 Phase 3 atropine
23 Amblyopia Treatment Study Completed NCT00001864 Phase 3 Atropine
24 A Randomized Trial of Full-time Bangerter Filters Versus Part-time Daily Patching for the Treatment of Moderate Amblyopia in Children Completed NCT00525174 Phase 3
25 A Randomized Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children 3 to <7 Years Old Completed NCT00091923 Phase 3
26 A Randomized Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds Completed NCT00315328 Phase 3 Atropine
27 Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity Completed NCT01203436 Phase 2, Phase 3
28 A Multicenter, Double-blind, Randomized, Placebo-controlled Study of Weight-Reduction and/or Low Sodium Diet Plus Acetazolamide vs Diet Plus Placebo in Subjects With Idiopathic Intracranial Hypertension With Mild Visual Loss Completed NCT01003639 Phase 2, Phase 3 Acetazolamide;Placebo
29 A Randomized Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia in Children 7 to <13 Years Old Terminated NCT00587171 Phase 3
30 A Randomized Trial to Evaluate Combined Patching-Atropine for Residual Amblyopia Terminated NCT00506675 Phase 3 Atropine;Atropine
31 A Novel Therapeutic Strategy Targeting Photoreceptor Oxidative Damage in ABCR-related Retinal Degenerations Unknown status NCT01278277 Phase 1, Phase 2
32 Is Non-cycloplegic Photorefraction Applicable for Screening Refractive Risk Factors of Amblyopia? Completed NCT01308307 Phase 2
33 A Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia in 8 to 17 Year Olds Completed NCT00789672 Phase 2 levodopa/carbidopa;levodopa/carbidopa
34 Effectiveness of Telescopic Magnification in the Treatment of Amblyopia Completed NCT00970554 Phase 1, Phase 2
35 Evaluation and Development of a Novel Binocular Treatment (I-BiTTM) System Using Video Clips and Interactive Games to Improve Vision in Children With Amblyopia ('Lazy Eye'). Completed NCT01702727 Phase 2
36 Comparison of Photorefraction With Cycloautorefraction and Cycloretinoscopy at Emam Hosein Medical Centre in 2008-2009 Completed NCT00815581 Phase 1, Phase 2
37 Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants Completed NCT00349726 Phase 2 Inositol lower volume;Inositol higher volume;Placebo lower volume;Placebo higher volume
38 Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants Completed NCT01030575 Phase 2 Inositol lower volume;Inositol mid-level volume;Inositol high volume;Placebo low volume
39 THOR - Tübingen Choroideremia Gene Therapy Trial Open Label Phase 2 Clinical Trial Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1) Active, not recruiting NCT02671539 Phase 2
40 Pilot Study to Evaluate Docosahexaenoic Acid as Treatment for Residual Amblyopia Not yet recruiting NCT03402789 Phase 1, Phase 2 Docosahexaenoic Acid;Placebo Oral Tablet
41 Caffeine in Amblyopia Study Withdrawn NCT02594358 Phase 1, Phase 2 Caffeine
42 Randomised Occlusion Treatment of Amblyopia Study (ROTAS): Trial of Maximal Vs Substantial Doses of Occlusion to Evaluate Visual Outcome for Children With Amblyopia Completed NCT00274664 Phase 1
43 Investigation of Visual Plasticity by a Direct Current Stimulation of Occipital Cortex in Adult Amblyopia Completed NCT00097162 Phase 1
44 A Singapore Pilot Study To Evaluate The Efficacy Of A Computerized System For The Vision Improvement Of People With Low Myopia Completed NCT00348127 Phase 1
45 Monovision for Treatment of Diplopia Completed NCT01426672 Phase 1
46 A Randomized, Three-Sequence, Three-Period Crossover Study to Assess the Bioavailability and Pharmacokinetics of a Single Dose of Atropine Administered Sublingually in Healthy Adult Volunteers Completed NCT04290039 Phase 1 Atropine Sulfate Ophthalmic Solution;Atropine Sulphate Injection
47 Pilot Study To Evaluate The Efficacy Of Neurovision'S NVCâ„¢- Vision Correction Technology For The Improvement In Visual Acuity In Myopic Children And Slowing Down Of Myopia Progression Completed NCT00348218 Phase 1
48 Recovery From Amblyopia With Cholinesterase Inhibitors Recruiting NCT01584076 Phase 1 Donepezil
49 Dichoptic Virtual Reality Therapy for Amblyopia in Adults Terminated NCT02246556 Phase 1
50 Phase 1 Study of Topical Beta Blocker to Prevent the Proliferative Stage of Infantile Hemangioma Terminated NCT01434849 Phase 1 topical 0.5% Timolol maleate;Control (placebo) group
51 Efficacy and Safety of Eyetronix Flicker Glasses to the Treatment of Anisometropic Amblyopia in Chinese Children Unknown status NCT02970708
52 Early Vision Screening With Automated Photorefraction in Pre-term, Low-birth- Weight and Development-delay Children in Far-Eastern Memorial Hospital, Taiwan Unknown status NCT02678468
53 Will Perceptual Learning Via Video Game Playing Improve Visual Acuity, Stereopsis and Fixation Stability in Mild Amblyopes? Part 2 Study Unknown status NCT02995174
54 Determining the Efficacy of Full-time Occlusion Therapy in Severe Amblyopia at All Ages Unknown status NCT02113709
55 The Role of Interactive Binocular Treatment System in Amblyopia Therapy Unknown status NCT02740725
56 The Use of Interactive Binocular Treatment (I-BiT) for the Management of Anisometropic, Strabismic and Mixed Amblyopia in Children Aged 3.5 - 12 Years Unknown status NCT02810847
57 MRI-based Biomarkers for the Prognosis Judgement of Punctate White Matter Lesions in Neonates: a Longitudinal Multicenter Study Unknown status NCT02637817
58 The Effects of Regular Eye-training With a Mobile Device on Adult Patients With AMD Unknown status NCT03461393
59 An Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old Completed NCT00669539
60 Refractive and Strabismic Amblyopia Risk Factors Detected by Infrared Photoscreener and School Bus Skiascopy Completed NCT03668067
61 Stochastic Resonance Applied to Amblyopia Training and the Plasticity of Brain Completed NCT04213066
62 Comparative Validation of the Birefringent Amblyopia Screener With Isolated Small-angle Strabismus Completed NCT04195711
63 Standard Amblyopia Therapy in Adult Amblyopes Completed NCT03341780
64 Prospective Evaluation of a Smartphone Application, GoCheckKidsâ„¢, to Detect Amblyopia Risk Factors in Young Children Completed NCT03447171
65 Pediatric Vision Scanner for the Eradication of Amblyopia Completed NCT01726842
66 Validation of a Questionnaire Assessing Quality of Life in Children With Amblyopia and Strabismus Completed NCT02880488
67 Assessment of Device for Treatment of Amblyopia Completed NCT02003235
68 Analysis of Spectral Domain Optical Coherence Tomography Measurements in Amblyopia Completed NCT01179763
69 Prospective Evaluation of a Smartphone Application, GoCheckKidsâ„¢ as a Photo Screening Tool in a Pediatric Population Completed NCT03119675
70 Pediatric Vision Scanner 4 (PVS4) Completed NCT01832883
71 Luminopia VR Device Pilot Study Completed NCT02782117
72 MEPEDS New Device Pediatric Vision Scanner Completed NCT01706991
73 Does Video Game Play Induce Plasticity in the Visual System of Adults With Amblyopia? Completed NCT01223716
74 Multimodal Physician Intervention to Detect Amblyopia (Recruiting Title "Equipping Primary Care Physicians to Improve Care for Children") Completed NCT01109459
75 Vision Screening of the Four Year Old Children for the Detection of Amblyopia in The Town of Zagreb Completed NCT01430247
76 Study of Binocular Computer Activities for Treatment of Amblyopia Completed NCT02200211
77 Amblyopia and Strabismus Testing in Pediatrics Completed NCT02536963
78 Efficacy of Over-glasses Patch Treatment for Amblyopia in Children :OPTA Study, A Prospective Randomized Clinical Trial Completed NCT03080285
79 Analysis of Retinal Nerve Fiber Layer and Macular Thickness After Congenital Cataract Surgery Completed NCT03621579
80 Bilateral Refractive Amblyopia Treatment Study Completed NCT00305955
81 Detection of Hyperopia by Photoscreener GoCheckKids With Glow Fixation Device Completed NCT04297969
82 To Observe and Determine Macular Thickness Changes Before and After Cataract Surgery Completed NCT04077489
83 Associated Professor, Director of Strabismus Department Completed NCT04432181
84 Changes in Refractive Error in Patients With Both Partially Refractive Esotropia and Amblyopia Completed NCT04429659
85 Glasses Versus Observation for Moderate Hyperopia in Young Children (HTS1) Completed NCT01515475
86 Disinvestment Study of Population-Based Vision Screening in Preverbal Children in the Netherlands Completed NCT01675193
87 The Efficacy of a Visual Screening Program to Reduce Later Amblyopia and Untreated Refractive Errors Completed NCT02458846
88 Performance of Two Photoscreeners With Enhanced Housing Completed NCT04068129
89 Exercise Interventions of Eye Muscles Post Strabismus Surgery Completed NCT04303832
90 AquaLase Capsule Wash for Pediatric Eyes Completed NCT00756327
91 Evaluation of a Visual Acuity Testing Software for Children, VisionQuest 20/20 Completed NCT00366756
92 Evaluation and Treatment Protocol for Patients With Pediatric Eye Diseases and Strabismus Completed NCT00006422
93 Binocular Treatment of Amblyopia Before and After Strabismus Surgery Completed NCT01791946
94 Visual Outcomes After Implantation of a Segmental Refractive Multifocal Intraocular Lens Following Cataract Surgery Completed NCT03452969
95 Visual Performance of New Apodized Diffractive Multifocal IOL With Addition of Plus Three Completed NCT01027533
96 Test-Retest Variability of Quick Contrast Sensitivity Function Testing Completed NCT02177669
97 A Long-term Postoperative Outcome After Bilateral Congenital Cataract Surgery in Eyes With Microphthalmos Completed NCT01818037
98 Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis Completed NCT02843438 Anti-toxoplasmosis treatment;Anti-inflammatory treatments
99 Effect of Neuromuscular Blockade on the Oculomotor by Not Squinting Child Completed NCT02360969
100 Effect of the Timing of Lens-removal Cataract Surgery on Postoperative Complications Rate Among Patients With Bilateral Congenital Cataracts Completed NCT02581046 Subconjunctival dexamethasone and general anesthesia
101 Wavefront Analysis and Contrast Sensitivity After Cataract Surgery With Akreos AO Intraocular Lens Implantation: Clinical Comparative Study Completed NCT00863759
102 Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Nystagmus or Strabismus Completed NCT00001861
103 Assessing the Functional and Psychosocial Impact of Strabismus in Asian Children Using the AS-20 and IXTQ Questionnaires Completed NCT01608828
104 Antioxidant Systems and Age-Related Macular Degeneration Completed NCT00668213
105 Tertiary Care Based Visual Developmental Diseases Management Model Among Preschool Children in China: a Cluster Randomized Controlled Trial Completed NCT03251456
106 A Novel Acuity Testing Method Completed NCT00013936
107 Effect of a Mobile Phone Short Message Service (SMS) on Childhood Cataract Follow-up Adherence in China Completed NCT01417819
108 Prescription of Hemangiol in the Treatment of Proliferative Infantile Hemangiomas Requiring Systemic Treatment: Post Marketing Surveillance Study Completed NCT04105517
109 Congenital Esotropia Observational Study (CEOS) Completed NCT00000163
110 Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration Completed NCT04084587
111 Evaluation of Refractive Status and Ophthalmological Problems of Prematurity Completed NCT01045616
112 Efficacy of Coloured Overlays and Lenses for Adults With Reading Difficulty Completed NCT02680223
113 Augmented Medial Rectus Muscle Recession Versus Medial Rectus Recession With Posterior Scleral Fixation in Partially Accommodative Esotropia Completed NCT02413463
114 Evaluation of Choroidal Thickness Using Spectral Optical Coherence Tomography in Pseudoexfoliation Glaucoma and Primary Open Angle Glaucoma Completed NCT03373942
115 Evaluation of the Acrysof Toric SN60T3 Intraocular Lens in Patients With Predicted Residual Corneal Astigmatism Between 0.75 and 1.00 D. Completed NCT00542581
116 Monocular Action Video Game Versus Passive Occlusion In The Treatment Of Amblyopia: A Randomized Controlled Trial Recruiting NCT04313257
117 Examination of New Visual Acuity and Clinical Crowding Tests for Better Detection of Amblyopia Recruiting NCT03505606
118 Augmenting Patching Treatment for Amblyopia With Physical Exercise Recruiting NCT03822806
119 A Phase 3 Randomized, Single-blind, Multicenter, Clinical Control Study to Evaluate the Efficacy and Safety of Caterna Virtual Reality Facilitating Treatment Patients With Amblyopia in Children Recruiting NCT04238065
120 Objective Adherence With Optical Correction in Children With Bilateral and Unilateral Refractive Amblyopia Recruiting NCT03780205
121 Luminopia One Amblyopia Vision Improvement Study Recruiting NCT03608150
122 Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia Recruiting NCT02687581
123 Intense vs Standard Regimens of Intermittent Occlusion Therapy for Unilateral Moderate Amblyopia in Children Recruiting NCT02767856
124 Treating Amblyopia in Adults With Interactive Video Games Recruiting NCT03906994
125 Dichoptic Video Treatment for Amblyopia in Children Age 3-7 Years Recruiting NCT03825107
126 Binocular Amblyopia Treatment Recruiting NCT03288948
127 Improving Spatial and Temporal Vision in Adult and Juvenile Amblyopia Recruiting NCT01115283
128 Towards Developing a Perceptual Learning Treatment for Amblyopia Recruiting NCT03788031
129 Feasibility and Efficacy of Transcorneal Electrical Stimulation (TES) for the Treatment of Amblyopia Recruiting NCT02495935
130 Oculomotor Disorders: Experimental and Clinical Study Recruiting NCT04310241
131 Binocular iPad Sub-Study; Suppression in Amblyopia Recruiting NCT02365090
132 The Research of the Neural Mechanisms Underlying Astigmatism Recruiting NCT03735602
133 A Comparative Study Between Dissociative Treatment and Binocular Interactive Treatment in Amblyopia Recruiting NCT03255707
134 Neurovascular Coupling in Subjects With Amblyopia Recruiting NCT01746693
135 Binocular Visual Therapy and Video Games for Amblyopia Treatment. Recruiting NCT03655912
136 A Randomised Clinical Trial Objectively Comparing the Effect of Patching Therapy With Video Gaming for Amblyopia Recruiting NCT03767985
137 Optical Coherence Tomography Angiography Analysis After Childhood Lensectomy Recruiting NCT04217772
138 Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences Recruiting NCT03940222
139 Phase 2a Two-site Randomised Controlled Trial to Determine Safety of and Adherence With a New 'Binocularly Balanced Viewing' Treatment for Unilateral Amblyopia Compared With Standard Treatment in Children Age 3-8 Years Recruiting NCT03754153
140 New Pediatric Patching Method to Improve Compliance Recruiting NCT02236351
141 The Effect of Peripheral Defocus on Axial Growth and Modulation of Refractive Error in Hyperopes Recruiting NCT02686879
142 Monofocal Extended Range of Vision (MERoV) Study Recruiting NCT04011696
143 Medication Compliance in the Paediatric Uveitis Population Reported by the Patients and Parents Recruiting NCT04148365
144 Binocular Dig Rush Game Treatment for Amblyopia Active, not recruiting NCT02983552
145 Photorefractive Keratectomy for Anisometropic and Isoametropic Amblyopia in Children Refractory to Conventional Treatment Active, not recruiting NCT03610997
146 Optimized Visual Recovery in Adult Human Amblyopia Through Binocular Deprivation Active, not recruiting NCT02685423
147 Mobile Medical Application for Cost-effective Strabismus Screening Active, not recruiting NCT03450980
148 The Long-Term Efficacy of Overminus Lens Therapy in Intermittent Exotropia Active, not recruiting NCT03952702
149 Use of Multifocal Contact Lenses to Stimulate Axial Elongation in Axial Hyperopia Active, not recruiting NCT00950924
150 A Randomized Trial of Bilateral Lateral Rectus Recession Versus Unilateral Lateral Rectus Recession With Medial Rectus Resection for Intermittent Exotropia Active, not recruiting NCT01032603
151 Visual Functional Connectivity and Visual Function in Amblyopia Before and After TMS and/or Binocular Treatment Enrolling by invitation NCT03151200
152 Improving Visual Functions in Young Children With Amblyopia Through Perceptual Learning Not yet recruiting NCT02555384
153 Effect of 3D Movie Viewing on Stereopsis in Strabismus and / or Anisometropic Amblyops Not yet recruiting NCT04315649
154 Virtual Reality Game Playing in Amblyopia Therapy Not yet recruiting NCT04261868
155 The Effect of Light Deprivation on Visual Functions in Adult Amblyopes Not yet recruiting NCT02799836
156 Deploying Retinal Birefringence Imaging in to the Clinic for Pediatric Vision Screening Not yet recruiting NCT03919708
157 A Randomized Trial to Evaluate Sequential vs Simultaneous Spectacles Plus Patching for Amblyopia in Children 3 to <13 Years Old Not yet recruiting NCT04378790
158 Evaluation of the GoCheck Kids Mobile Vision Screening Application and the Welch Allyn Spot Vision Screener Not yet recruiting NCT04321538
159 Patching Versus Dichoptic Stimulation Using Virtual Reality in Anisometropic Amblyopia Not yet recruiting NCT04302701
160 Macular and Retinal Changes in Unilateral Amblyopia Using Optical Coherence Tomography Not yet recruiting NCT04092361
161 A Patch Free Treatment for Young Children With Amblyopia Not yet recruiting NCT04086524
162 Highlighting the Benefits of a Screening Protocol Delivered by Orthoptists to Identify Visual Impairment in Children Aged 3 to 4 Not yet recruiting NCT04395560
163 Müller's Muscle as a New Proprioceptive Organ Evidence From Immunohistochemical Staining and Electron Microscopy to Verify That the Upper Eyelid Müller's Muscle Contains Proprioceptive Innervation for Reflexive Correction of Eyelid Position Not yet recruiting NCT03396627
164 Improving Control of Alignment in Intermittent Esotropia Not yet recruiting NCT04199871
165 Botulinum Toxin Augmented Surgery Versus Conventional Surgery in the Management of Large Angle Infantile Esotropia Not yet recruiting NCT03266549
166 Use of a Novel, Objective Optokinetic Contrast Device to Determine Scotopic Range Visual Function and Discriminate Between Patients With and Without Glaucoma Suspended NCT02014597
167 Comparison of AmblyzTM Glasses and Patching for Amblyopia Terminated NCT01973348
168 Randomized Clinical Trial of OCT-guided Laser-assisted Lamellar Anterior Keratoplasty in Children Terminated NCT01579643
169 Excimer Laser Surgery for Anisometropic Amblyopia Withdrawn NCT03342235
170 Amblyopia and Neurovascular Coupling in the Retina of Humans Withdrawn NCT00312390
171 Évaluation de l'Utilisation d'un Photoscreener Comme méthode de dépistage Des problèmes Ophtalmologiques pédiatriques en Haïti Withdrawn NCT02655432

Search NIH Clinical Center for Suppression Amblyopia

Cochrane evidence based reviews: amblyopia

Sources

Genetic Tests for Suppression Amblyopia

About this section
Sources

Anatomical Context for Suppression Amblyopia

About this section

MalaCards organs/tissues related to Suppression Amblyopia:

40
Eye, Testes, Cortex, Brain, Retina, Endothelial, Pituitary
Sources

Publications for Suppression Amblyopia

About this section

Articles related to Suppression Amblyopia:

(showing 7132, show less)
# Title Authors PMID Year
1
Short-term monocular deprivation reduces inter-ocular suppression of the deprived eye. 61
32460171 2020
2
Quantitative analysis of macular and peripapillary microvasculature in adults with anisometropic amblyopia. 61
32200510 2020
3
Abnormal Red Reflex: Etiologies in a Pediatric Ophthalmology Population. 61
32503396 2020
4
Consecutive strabismus after infantile nystagmus syndrome surgery and potential risk factors. 61
32307586 2020
5
Evaluating Amblyopia Treatment Success Using the American Academy of Ophthalmology IRIS50 Measures. 61
32199623 2020
6
Femtosecond Laser-Assisted LASIK in Children With Hyperopia and Anisometropic Amblyopia: 7 Years of Follow-up. 61
32521023 2020
7
Transcranial Magnetic Stimulation in Adults With Amblyopia. 61
31453915 2020
8
Analysis of the potential impact of strabismus with and without amblyopia on visual-perceptual and visual-motor skills evaluated using TVPS-3 and VMI-6 tests. 61
32535162 2020
9
Benefit of Patching Therapy to Minimize Amblyopia After Retinoblastoma Treatment. 61
32507274 2020
10
Associations between Attention-Deficit/Hyperactivity Disorder and Ocular Abnormalities in Children: A Population-based Study. 61
31878821 2020
11
Contributing ocular comorbidity to end-of-life visual acuity in medically treated glaucoma patients, ocular hypertension and glaucoma suspect patients. 61
32494040 2020
12
VEP estimation of visual acuity: a systematic review. 61
32488810 2020
13
Efficacy of toric intraocular lens implantation with high corneal astigmatism within the United Kingdom's National Health Service. 61
31844167 2020
14
Clinical safety and efficacy of a hydrophilic acrylic intraocular lens in a real-world population: a 1-year follow-up retro-prospective study. 61
32527240 2020
15
Presentation, surgery and 1-year outcomes of childhood cataract surgery in Tanzania. 61
32522793 2020
16
The rare phenomenon of Marcus-Gunn jaw winking without ptosis: Report of 14 cases and review of the literature. 61
32461447 2020
17
Understanding the Impact of Residual Amblyopia on Functional Vision and Eye-Related Quality of Life using the PedEyeQ. 61
32511967 2020
18
Predictive factors for the perceptual learning in stereodeficient subjects. 61
32561200 2020
19
Visual Outcomes in Presumed Congenital Foveal Toxoplasmosis. 61
32035830 2020
20
Use of a new composite index to demonstrate improved stereoacuity after training on stimuli with dichoptically asymmetric contrast. 61
31735256 2020
21
Comment on the article: multifocal electroretinography in amblyopia. 61
32232567 2020
22
Comparison of Pre-Treatment vs. Post-Treatment Retinal Vessel Density in Children with Amblyopia. 61
32412887 2020
23
Baseline and Clinical Factors Associated with Response to Amblyopia Treatment in a Randomized Clinical Trial. 61
32413002 2020
24
Efficacy of interventions for amblyopia: a systematic review and network meta-analysis. 61
32450849 2020
25
Implied Motion From Form Shows Motion Aids the Perception of Global Form in Amblyopia. 61
32460320 2020
26
Vision training with VEP biofeedback in amblyopia after the critical period. 61
32468275 2020
27
Improved adherence and treatment outcomes with an engaging, personalized digital therapeutic in amblyopia. 61
32433490 2020
28
Reply to the letter to the editor: Multifocal electroretinography in amblyopia. 61
32222829 2020
29
Activation of somatostatin interneurons by nicotinic modulator Lypd6 enhances plasticity and functional recovery in the adult mouse visual cortex. 61
32467358 2020
30
Prevalence, causes and risk factors of reduced VA and persistent reduced VA among preschool children in Eastern China. 61
32462748 2020
31
Deep Learning-Based Prediction of Refractive Error Using Photorefraction Images Captured by a Smartphone: Model Development and Validation Study. 61
32369035 2020
32
Intraocular Pressure Reduction After Real-world Cataract Surgery. 61
32366779 2020
33
Visual Acuity and Foveal Structure in Eyes with Fragmented Foveal Avascular Zones. 61
31956075 2020
34
Clinical spectrum and treatment outcomes of patients with nanophthalmos. 61
32461562 2020
35
Effect of Stimulus Orientation on Visual Function in Children with Refractive Amblyopia. 61
32392311 2020
36
Treatment of Congenital Ptosis in Infants With Associated Amblyopia Using a Frontalis Muscle Flap Eyelid Reanimation Technique. 61
32467524 2020
37
Practice Patterns in the Surgical Management of Pediatric Traumatic Cataracts. 61
32453853 2020
38
Ocular Findings in Pontine Tegmental Cap Dysplasia. 61
32398424 2020
39
Saccadic reaction time and ocular findings in phenylketonuria. 61
32450880 2020
40
Risk factors for spontaneous consecutive exotropia in children with refractive and nonrefractive accommodative esotropia. 61
32108919 2020
41
Evaluation of the Spot Vision Screener in comparison with the orthoptic examination in visual screening in 3-5 year-old schoolchildren. 61
32143821 2020
42
Evaluation of the Spot Vision Screener in School-Aged Children. 61
32453847 2020
43
Detection of Amblyogenic Refractive Error Using the Spot Vision Screener in Children. 61
32413003 2020
44
Short-term Perceptual Learning Game Does Not Improve Patching-Resistant Amblyopia in Older Children. 61
32453851 2020
45
Neuroplasticity in adult human visual cortex. 61
32092315 2020
46
Psychomotor, Psychosocial and Reading Skills in Children with Amblyopia and the Effect of Different Treatments. 61
32281918 2020
47
National and sub national prevalence of Amblyopia and its trends from 1990 to 2018 in Iran. 61
32321688 2020
48
Wiedemann-steiner syndrome with a de novo mutation in KMT2A: A case report. 61
32311999 2020
49
Spectacle correction versus no spectacles for prevention of strabismus in hyperopic children. 61
32240551 2020
50
Influence of prenatal environment and birth parameters on amblyopia, strabismus, and anisometropia. 61
32151573 2020
51
Binocular discrepancy in lateral rectus muscle attachment in intermittent exotropia with eye dominance. 61
32314031 2020
52
Craniosynostosis and oculomotor disorders. 61
31866515 2020
53
Feasibility of Eye Movement Recordings with the SMI Tracking Bar in 10- to 11-Year-Old Children Performing a Reading Task. 61
32330981 2020
54
Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review. 61
32078919 2020
55
Severe reverse amblyopia with atropine penalization. 61
31953022 2020
56
Lamellar Keratoplasty in Children. 61
32305350 2020
57
When to screen for amblyopia. 61
32142758 2020
58
Optical coherence tomography angiography in primary eye care. 61
32285493 2020
59
Intense versus standard regimens of intermittent occlusion therapy for unilateral moderate amblyopia in children: study protocol for a randomized controlled trial. 61
32345348 2020
60
Ophthalmic Pathology in the Offspring of Pregnant Women with Gestational Diabetes Mellitus. 61
31997119 2020
61
Long-term refractive outcomes in children with early diagnosis of moderate to high hyperopia. 61
32316817 2020
62
The prevalence of refractive error and visual impairment among New Zealand children in a community with significant socioeconomic disadvantage: is current preschool vision screening effective? 61
32325466 2020
63
Active efficient coding explains the development of binocular vision and its failure in amblyopia. 61
32123102 2020
64
Interocular suppressive interactions in amblyopia depend on spatial frequency. 61
32044586 2020
65
Effect of Primary Occlusion Therapy in Asymmetric, Bilateral Amblyopia. 61
31712066 2020
66
[An amblyopia revealing extended fibers in myelin]. 61
31973974 2020
67
Incidence of Strabismus and Amblyopia Among Children Initially Diagnosed With Pseudostrabismus Using the Optum Data Set. 61
31730842 2020
68
Ocular and adnexal anomalies in craniofacial microsomia: a systematic review. 61
32217034 2020
69
[Keratoplasty in children : Indications and results]. 61
31713069 2020
70
Attention in visually typical and amblyopic children. 61
32232378 2020
71
Smartphone use in ophthalmology: What is their place in clinical practice? 61
31541618 2020
72
Two Patterns of Interocular Delay Revealed by Spontaneous Motion-in-Depth Pulfrich Phenomenon in Amblyopes with Stereopsis. 61
32181800 2020
73
Occlusion for stimulus deprivation amblyopia. 61
32203629 2020
74
Multifocal electroretinography in amblyopia. 61
31900648 2020
75
Evaluation of All Causes of Visual Function Loss in Children With Congenital Blepharoptosis. 61
32203593 2020
76
Accuracy of noncycloplegic photorefraction using Spot photoscreener in detecting amblyopia risk factors in preschool children in an Indian eye clinic. 61
32057013 2020
77
Unilateral Abducens Nerve Palsy Following Perinatal Stroke of the Middle Cerebral Artery. 61
32176807 2020
78
Comparison of a New, Filter-Free Stereopsis Test (BEST) With the Randot Stereotest in a Pediatric Cohort. 61
32203597 2020
79
Reduced stereoacuity as a predictor for clinically significant convergence insufficiency. 61
32188680 2020
80
Visual prognosis of posterior and combined persistent fetal vasculature. 61
30712383 2020
81
[The performance of visual photoscreening for Chinese preschool children aged 4 to 5 years]. 61
32187947 2020
82
[Timing of congenital cataract surgery : Amblyopia versus aphakic glaucoma]. 61
32076840 2020
83
Refinement strategies in photoscreening for the detection of amblyopia risk factors in 12-to-24-month-old children. 61
32223997 2020
84
Binocular game versus part-time patching for treatment of anisometropic amblyopia in Chinese children: a randomised clinical trial. 61
31272953 2020
85
Amblyopia, deprivation and health disparities research: challenges in 2020. 61
32094471 2020
86
Effects of Monocular Perceptual Learning on Binocular Visual Processing in Adolescent and Adult Amblyopia. 61
32062454 2020
87
Binocular Treatment of Amblyopia: A Report by the American Academy of Ophthalmology. 61
31619356 2020
88
Surgical Treatment of Severe Ptosis by Modified Brow Suspension Technique. 61
32110644 2020
89
Visual improvement in amblyopic eye following treatment-induced vision loss in dominant eye with uveal melanoma. 61
31097438 2020
90
Spontaneous regression of congenital corneal opacity. 61
31768679 2020
91
Colour vision testing in young children with reduced visual acuity. 61
31469512 2020
92
Infantile simple dacryops: clinicopathological correlation and immunocharacterization. 61
31821863 2020
93
Nanophthalmos in children: morphometric and clinical characterization. 61
32058088 2020
94
Effectiveness of the iPhone GoCheck Kids smartphone vision screener in detecting amblyopia risk factors. 61
31904429 2020
95
Refractive Errors and Amblyopia Among Children Screened by the UCLA Preschool Vision Program in Los Angeles County. 61
31647932 2020
96
National consensus statement regarding pediatric eye examination, refraction, and amblyopia management. 61
31957721 2020
97
Long-term visual and treatment outcomes of whole-population pre-school visual screening (PSVS) in children: a longitudinal, retrospective, population-based cohort study. 61
32099079 2020
98
Plusoptix photoscreener use for paediatric vision screening in Flanders and Iran. 61
31197950 2020
99
Comparison of photoscreening and autorefractive screening for the detection of amblyopia risk factors in children under 3 years of age. 61
31926368 2020
100
Positive predictive value and screening performance of GoCheck Kids in a primary care university clinic. 61
31940501 2020
101
Outcomes of surgery in patients with sensory exotropia. 61
31836297 2020
102
Objective Assessment of the Effect of Optical Treatment on Magnocellular and Parvocellular-biased Visual Response in Anisometropic Amblyopia. 61
32058564 2020
103
Effect of optical correction on choroidal structure in children with anisohypermetropic amblyopia. 61
32324782 2020
104
Systematic Evaluation of Levodopa Effect on Visual Improvement in Amblyopia: A Meta-analysis. 61
31738189 2020
105
Amblyopia therapy in children with penetrating corneal injuries. 61
32309121 2020
106
Amblyopia Risk Factors in Newborns With Congenital Nasolacrimal Duct Obstruction. 61
31972039 2020
107
Long-term Monocular Deprivation during Juvenile Critical Period Disrupts Binocular Integration in Mouse Visual Thalamus. 61
31767678 2020
108
Sensory Eye Dominance: Relationship Between Eye and Brain. 61
32021530 2020
109
Two-Year Outcomes of Infants with Stage 2 or Higher Retinopathy of Prematurity: Results from a Large Multicenter Registry. 61
31480086 2020
110
Investigation of Stress and Distress Experienced by Guardians of Children with Strabismus and/or Amblyopia. 61
31858895 2020
111
Comparative AAPOS Validation of the Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus. 61
32099317 2020
112
Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia. 61
32256044 2020
113
Strabismus Patterns in Patients with Intrauterine Drug Exposure. 61
31852370 2020
114
Anterior lamellar keratoplasty for the management of a central dermoid tumour in a baby. 61
31735598 2020
115
[Factors influencing target refraction in children with pseudophakia after extraction of congenital cataract]. 61
32504483 2020
116
Evaluating the Acute Effect of Stereoscopic Recovery by Dichoptic Stimulation Using Electroencephalogram. 61
32351615 2020
117
Stereoacuity Improvement using Random-Dot Video Games. 61
32009644 2020
118
Treatment modalities in Duane's Retraction Syndrome. 61
32090038 2020
119
Passive optical device for nystagmus correction and ophthalmic resolution enhancement. 61
32225325 2020
120
Refractive and Visual Outcomes After Implantation of a Secondary Toric Sulcus Intraocular Lenses. 61
32546940 2020
121
Prevalence of Visual Impairment and Associated Factors Among Primary Schoolchildren in Addis Ababa, Central Ethiopia. 61
32210530 2020
122
A computerized resolution visual acuity test in preschool and school age children. 61
32090039 2020
123
Surgical Intervention of Periocular Infantile Hemangiomas in the Era of β-Blockers. 61
31809485 2020
124
Inter-Ocular Symmetry of Vascular Density and Retinal Thickness in Unilateral Anisometropic Amblyopia. 61
32440093 2020
125
Correlation between higher-order aberrations and visual acuity recovery (CoHORT) after spectacles treatment for pediatric refractive amblyopia: A pilot study using iDesign measurement. 61
32059018 2020
126
[Comparative assessment of the parameters of visual fixation in amblyopia of different origin]. 61
32366066 2020
127
Three horizontal muscle surgery for large-angle esotropia: success rate and dose-effect ratio. 61
32399416 2020
128
Comparison of Retinal Vascular Structure in Eyes With and Without Amblyopia by Optical Coherence Tomography Angiography. 61
31972041 2020
129
Is amblyopia associated with school readiness and cognitive performance during early schooling? Findings from the Millennium Cohort Study. 61
32559208 2020
130
Anterior chamber depth and axial length affect clinical performance of Spot Vision Screener. 61
31664336 2020
131
Ophthalmologic Manifestations and Retinal Findings in Children with Down Syndrome. 61
32089873 2020
132
Effectiveness of combined dichoptic therapy, binocular vision therapy, and part-time patching for the management of amblyopia in adults. 61
31856546 2020
133
Enhanced Gray Matter Volume Compensates for Decreased Brain Activity in the Ocular Motor Area in Children with Anisometropic Amblyopia. 61
32377181 2020
134
Performance of Two Photoscreeners Enhanced by Protective Cases. 61
32546951 2020
135
Understanding the development of amblyopia using macaque monkey models. 61
31871163 2019
136
[Treatment monitoring and innovations in amblyopia treatment]. 61
31552468 2019
137
Analysis of Macular Vessel Density and Foveal Avascular Zone in Adults with Amblyopia. 61
31283893 2019
138
Comparison between patching and interactive binocular treatment in amblyopia: A randomized clinical trial. 61
31844795 2019
139
Accuracy of online health information on amblyopia and strabismus. 61
31610240 2019
140
Brain abnormalities in infantile esotropia as predictor for consecutive exotropia. 61
31637944 2019
141
[Do children with strabismus receive ophthalmic treatment? : Results from the KiGGS (German Health Interview and Examination Survey for Children and Adolescents) baseline survey (2003-2006)]. 61
30980175 2019
142
The Danish Rural Eye Study: prevalence of strabismus among 3785 Danish adults - a population-based cross-sectional study. 61
31025814 2019
143
Amblyopia: Detection and Treatment. 61
31845774 2019
144
Current Management of Childhood Amblyopia. 61
31833253 2019
145
Visual outcome and surgical results in children with Marfan syndrome. 61
31325202 2019
146
Posterior microphthalmos with good visual acuity: A case report. 61
31763497 2019
147
Optical Coherence Tomography Normative Peripapillary Retinal Nerve Fiber Layer and Macular Data in Children 0-5 Years of Age. 61
31271744 2019
148
Children with congenital and childhood cataract require frequent follow-up visits and examinations in general anaesthesia: considerations for the strain on families. 61
30860655 2019
149
[Vision screening in children: Review of the literature]. 61
31733915 2019
150
Long-term functional outcomes of different subtypes of primary congenital glaucoma. 61
31871047 2019
151
The impact of vision screening in preschool children on visual function in the Swedish adult population. 61
31127702 2019
152
Penetrating Keratoplasty for Keratoconus in Vietnamese Patients. 61
32215079 2019
153
Evidence-based clinical practice guidelines for the periodic eye examination in children aged 0-5 years in Canada. 61
31767160 2019
154
The practise of paediatric optometry in a low-resource environment. 61
31852024 2019
155
Non-invasive current stimulation in vision recovery: a review of the literature. 61
31884495 2019
156
Ophthalmologic disorders and risk factors in children with autism spectrum disorder. 61
31676470 2019
157
Long-term visual outcomes following abusive head trauma with retinal hemorrhage. 61
31655114 2019
158
Altered functional interactions between neurons in primary visual cortex of macaque monkeys with experimental amblyopia. 61
31553685 2019
159
Homeostatic regulation of perisynaptic matrix metalloproteinase 9 (MMP9) activity in the amblyopic visual cortex. 61
31868167 2019
160
Quality of life and mental health in amblyopic children treated with and without occlusion therapy. 61
31678257 2019
161
Evaluation of Pupillary Light Reflex in Amblyopic Eyes Using Dynamic Pupillometry 61
31893585 2019
162
Altered cortical morphology of visual cortex in adults with monocular amblyopia. 61
30854758 2019
163
Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis. 61
31704700 2019
164
Full time occlusion VS part time occlusion in treatment of monocular amblyopia. 61
31777509 2019
165
Optical Coherence Tomography Angiography in Amblyopia. 61
31755981 2019
166
Abnormal Monocular and Dichoptic Temporal Synchrony in Adults with Amblyopia. 61
31747686 2019
167
Periocular infantile hemangiomas: Characteristics, ocular sequelae, and outcomes. 61
31448460 2019
168
Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity. 61
31697304 2019
169
Performance of the 2WIN Photoscreener With "CR" Strabismus Estimation in High-Risk Patients. 61
31077668 2019
170
Management of a Large Congenital Hemangioma Obstructing Visual Axis: A Case Report and Review of Literature. 61
31593044 2019
171
Vision Testing Among Children Aged 3-5 Years in the United States, 2016-2017. 61
31751209 2019
172
Biallelic ERBB3 loss-of-function variants are associated with a novel multisystem syndrome without congenital contracture. 61
31752936 2019
173
Abnormal sensory eye dominance in stereoanomalous subjects. 61
31747692 2019
174
Epibulbar complex choristoma with simultaneous involvement of eyelid: a case report. 61
31718612 2019
175
Horizontal Gaze Palsy with Progressive Scoliosis: A Case Report and Literature Review. 61
31741681 2019
176
Aniseikonia and anisometropia: implications for suppression and amblyopia. 61
30791133 2019
177
[Orbital Disorders in Childhood]. 61
31412385 2019
178
Referral to community care from school-based eye care programs in the United States. 61
30978336 2019
179
Assessment of stereovision with digital testing in adults and children with normal and impaired binocularity. 61
31377344 2019
180
Objective and quantitative assessment of interocular suppression in strabismic amblyopia based on steady-state motion visual evoked potentials. 61
31585388 2019
181
[Ametropia among senegalese children in a hospital setting]. 61
31235321 2019
182
Ophthalmological management in craniosynostosis. 61
31574284 2019
183
Intact Visuospatial Cognition in Amblyopia: Results From the Gutenberg Health Study. 61
31743409 2019
184
Altered spontaneous brain activity in patients with strabismic amblyopia: A resting-state fMRI study using regional homogeneity analysis. 61
31616514 2019
185
Retinal oximetry in normal and amblyopic children: a pilot study. 61
30843376 2019
186
An Unexpected Spontaneous Motion-In-Depth Pulfrich Phenomenon in Amblyopia. 61
31735855 2019
187
The Role of Binocularity in Anisometropic Amblyopia. 61
31486743 2019
188
Amblyopia with Eccentric Fixation: Is Inverse Occlusion Still an Option? 61
31584348 2019
189
Effects of temporal frequency on binocular deficits in amblyopia. 61
31404553 2019
190
[The Use of a Microsensor in Therapy of Amblyopia]. 61
29117611 2019
191
Analysis of retinal nerve fiber layer thickness in anisometropic amblyopia via optic coherence tomography. 61
31270595 2019
192
Levodopa Plus Occlusion Therapy versus Occlusion Therapy Alone for Children with Anisometropic Amblyopia. 61
31875101 2019
193
Differential Experience-Dependent Plasticity of Form and Motion Mechanisms in Anisometropic Amblyopia. 61
31574139 2019
194
Autonomous early detection of eye disease in childhood photographs. 61
31616792 2019
195
Expanding the phenotypic spectrum of MBOAT7-related intellectual disability. 61
31282596 2019
196
The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity. 61
31078540 2019
197
Attention deficits in Amblyopia. 61
31030000 2019
198
The clinical characteristics of Duane retraction syndrome in Al-Medina region. 61
31920443 2019
199
Comparison of 2Win and plusoptiX A12R refractometers with Retinomax handheld autorefractor keratometer. 61
31539614 2019
200
Objective measurement of visual acuity by optokinetic nystagmus suppression in children and adult patients. 61
31526857 2019
201
[Syndrome of bilateral myelinated retinal nerve fibers, myopia and amblyopia: A case report]. 61
31182255 2019
202
Congenital glycosylation disorder: a novel presentation of coexisting anterior and posterior segment pathology and its implications in pediatric cataract management. 61
31153949 2019
203
[Evaluation of Ophthalmic Follow-up Care of Former Pre-term and Full-term Infants Aged from 4 to 10 Years in Germany - Results of the Wiesbaden Prematurity Study (WPS)]. 61
29117610 2019
204
Evaluation of Metabolite Changes in the Occipital Cortex of Patients with Idiopathic Infantile Nystagmus or Bilateral Ametropic Amblyopia by Magnetic Resonance Spectroscopy. 61
31612650 2019
205
Amblyopia treatment and quality of life: the child's perspective on atropine versus patching. 61
31329017 2019
206
Evaluation of static and dynamic pupil characteristics in hyperopic anisometropic amblyopia. 61
30284453 2019
207
[Congenital abnormalities of the optic disc]. 61
30935696 2019
208
Bilateral Congenital Corneal Opacities as an Early-Onset Ocular Feature of Kabuki Syndrome. 61
30950893 2019
209
Eye Conditions in Infants and Children: Amblyopia and Strabismus. 61
31454213 2019
210
Eye Tracking Abnormalities in School-Aged Children With Strabismus and With and Without Amblyopia. 61
31545863 2019
211
Clinical characteristics and mutation Spectrum of NF1 in 12 Chinese families with orbital/periorbital plexiform Neurofibromatosis type 1. 61
31533651 2019
212
Sex-specific difference in age distribution of congenital lower eyelid epiblepharon in a Japanese population. 61
31286315 2019
213
A comparison of ocular trauma scores in a pediatric population. 61
31511037 2019
214
[Recurrent maxillary sinus pleomorphic gonadoma into myoepithelial carcinoma: a case report]. 61
31446713 2019
215
Surgical intervention for paediatric blepharoptosis: a 6-year case series. 61
30244388 2019
216
Optical treatment of strabismic amblyopia. 61
31506980 2019
217
Treatment of amblyopia: part 5. 61
31456466 2019
218
Does successful surgical correction of childhood large angle exotropia in adults make any difference to binocularity and quality of life? 61
31335253 2019
219
The Importance of the Interaction Between Ocular Motor Function and Vision During Human Infancy. 61
31525140 2019
220
[Ocular torticollis is a diagnostic and surgical challenge]. 61
31543099 2019
221
Simplified updates on the pathophysiology and recent developments in the treatment of amblyopia: A review. 61
31436180 2019
222
Eye Conditions in Infants and Children: Vision Screening and Routine Eye Examinations. 61
31454212 2019
223
Biometry: a tool for the detection of amblyopia risk factor in children. 61
31183540 2019
224
Anisometropia and isoametropia associated with microstrabismus: effectiveness of late anti-amblyopia treatment. 61
31612190 2019
225
Ocular characteristics in a variant microcephalic primordial dwarfism type II. 61
31510961 2019
226
Evidence-based preschool-age vision screening: health policy considerations. 61
31514739 2019
227
Choosing appropriate tools and referral criteria for vision screening of children aged 4-5 years in Canada: a quantitative analysis. 61
31558460 2019
228
How Many Plusoptix S04 Measures Yield the Most Sensitive Amblyopia Screening? 61
31545864 2019
229
Comparison of the CAT-QoL and PedsQLTM instruments in measuring quality of life in amblyopia treatment: preliminary results. 61
31120350 2019
230
tDCS recovers depth perception in adult amblyopic rats and reorganizes visual cortex activity. 61
31078617 2019
231
Driver licensing and motor vehicle crash rates among young adults with amblyopia and unilateral vision impairment. 61
30769086 2019
232
Morphologic changes in the visual cortex of patients with anisometropic amblyopia: a surface-based morphometry study. 61
31375091 2019
233
Feasibility of monitoring compliance with intermittent occlusion therapy glasses for amblyopia treatment. 61
31271842 2019
234
Amblyopia Affects the ON Visual Pathway More than the OFF. 61
31189574 2019
235
The effect of asymmetrical accommodation on anisometropic amblyopia treatment outcomes. 61
31301347 2019
236
Conventional occlusion versus pharmacologic penalization for amblyopia. 61
31461545 2019
237
Analysis of Choroidal Vascularity in Children with Unilateral Hyperopic Amblyopia. 61
31434959 2019
238
Cost-Effectiveness of Limited Vitrectomy for Vision-Degrading Myodesopsia. 61
30849342 2019
239
Marcus Gunn Jaw-Winking Syndrome: a Case Report. 61
31762566 2019
240
Ocular dominance plasticity: A binocular combination task finds no cumulative effect with repeated patching. 61
31194984 2019
241
Novel BRPF1 mutation in a boy with intellectual disability, coloboma, facial nerve palsy and hypoplasia of the corpus callosum. 61
31176769 2019
242
Zone of retinal vascularization and refractive error in premature eyes with and without spontaneously regressed retinopathy of prematurity. 61
31229607 2019
243
Eyelid Thread-lifting Treatment for Periocular Infantile Hemangioma in an Extremely Premature Low-birth-weight Infant. 61
31592024 2019
244
Factors determining the outcome of paediatric exotropia surgery. 61
31424031 2019
245
Study on the High Functional Contact Lens Material with Superior Oxygen Transmissibility and Antibacterial Properties. 61
30913731 2019
246
[An investigation on professional performance of optometric refraction in spectacles stores in Anyang city of Henan Province]. 61
31422635 2019
247
Prevalence of anterior polar cataracts in children and risk factors for amblyopia. 61
30390373 2019
248
Foveal avascular zone and macular vessel density after correction for magnification error in unilateral amblyopia using optical coherence tomography angiography. 61
31382925 2019
249
Referral for Ophthalmology Evaluation and Visual Sequelae in Children With Primary Brain Tumors. 61
31373649 2019
250
Impaired Fellow Eye Motion Perception and Abnormal Binocular Function. 61
31387113 2019
251
Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens. 61
31429729 2019
252
Quantitative analysis of retinal microcirculation in children with hyperopic anisometropic amblyopia: an optical coherence tomography angiography study. 61
31112776 2019
253
Comparison of amblyopia in schoolchildren in Ireland and Northern Ireland: a population-based observational cross-sectional analysis of a treatable childhood visual deficit. 61
31401612 2019
254
Dichoptic De-Masking Learning in Adults With Amblyopia and Its Mechanisms. 61
31307059 2019
255
A Convenient and Robust Test to Quantify Interocular Suppression for Children With Amblyopia. 61
31384415 2019
256
Comparative study of visual dysfunctions in 6-10-year-old very preterm- and full-term-born children. 61
29916121 2019
257
Tribal Odisha Eye Disease Study (TOES) report # 5: Comparison of prevalence and causes of visual impairment among tribal children in native and urban schools of Odisha (India). 61
31238398 2019
258
OCT angiography of persistent hyaloid artery: a case report. 61
31272412 2019
259
A commonly occurring genetic variant within the NPLOC4-TSPAN10-PDE6G gene cluster is associated with the risk of strabismus. 61
31073882 2019
260
Implementation of a Virtual Reality rendered in Portable Devices for Strabismus Treatment based on Conventional Visual Therapy. 61
31947493 2019
261
Pituitary apoplexy secondary to pituitary macroadenoma, a diagnostic challenge 61
32242651 2019
262
A Review of Childhood Vision Screening Laws and Programs Across the United States. 61
31461584 2019
263
Visual Acuity and Ophthalmic Outcomes in the Year After Cataract Surgery Among Children Younger Than 13 Years. 61
31095258 2019
264
Oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. 61
30783259 2019
265
School screening in Coastal Karnataka. 61
31687626 2019
266
Regression of fetal vasculature and visual improvement in nonsurgical persistent hyperplastic primary vitreous: a case report. 61
31349817 2019
267
Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus? 61
31296236 2019
268
The Outcome of Scleral Lens Fitting for Keratoconus With Resolved Corneal Hydrops. 61
31170103 2019
269
Fellow Eye Deficits in Amblyopia. 61
31161888 2019
270
Duane's Retraction Syndrome in a Cohort of South African Children: A 20-Year Clinic-Based Review. 61
31322716 2019
271
Diagnostic test accuracy of Spot and Plusoptix photoscreeners in detecting amblyogenic risk factors in children: a systemic review and meta-analysis. 61
31236980 2019
272
Video interpretation and diagnosis of pediatric amblyopia and eye disease. 61
31364472 2019
273
Clinical investigation plan for the use of interactive binocular treatment (I-BiT) for the management of anisometropic, strabismic and mixed amblyopia in children aged 3.5-12 years: a randomised controlled trial. 61
31311577 2019
274
Analysis of macular, foveal, and retinal nerve fiber layer thickness in children with unilateral anisometropic amblyopia and their changes following occlusion therapy. 61
31238399 2019
275
Commentary: Analysis of macular, foveal and retinal nerve fiber layer thickness in children with unilateral anisometropic amblyopia and their changes following occlusion therapy. 61
31238400 2019
276
Comparison of higher order aberrations in amblyopic and non-amblyopic eyes in pediatric patients with anisometropic amblyopia. 61
31238401 2019
277
Don't Miss This! Red Flags in the Pediatric Eye Examination: Subnormal Acuity. 61
31329058 2019
278
Long-term Effects After Pediatric LASIK for Anisometropic Amblyopia in Two Patients. 61